SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr | ₹14,296 Cr | ₹15,948 Cr |
What is the latest Net Current Assets ratio of SUN PHARMACEUTICAL INDUSTRIES ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹26,449 Cr |
Mar2023 | ₹19,956 Cr |
Mar2022 | ₹17,656 Cr |
Mar2021 | ₹14,296 Cr |
Mar2020 | ₹15,948 Cr |
How is Net Current Assets of SUN PHARMACEUTICAL INDUSTRIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹26,449 Cr | 32.54 | |
Mar2023 | ₹19,956 Cr | 13.02 | |
Mar2022 | ₹17,656 Cr | 23.50 | |
Mar2021 | ₹14,296 Cr | -10.35 | |
Mar2020 | ₹15,948 Cr | - |
Compare Net Current Assets of peers of SUN PHARMACEUTICAL INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUN PHARMACEUTICAL INDUSTRIES | ₹405,817.6 Cr | 0.5% | -0.5% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,355.0 Cr | 1.3% | 10.7% | 49.3% | Stock Analytics | |
CIPLA | ₹122,929.0 Cr | 2.2% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,701.0 Cr | 4.7% | 11.9% | 14.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,502.0 Cr | 2% | -0.8% | 15.7% | Stock Analytics | |
MANKIND PHARMA | ₹98,151.0 Cr | 0.7% | -6.7% | 10.3% | Stock Analytics |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUN PHARMACEUTICAL INDUSTRIES | 0.5% |
-0.5% |
14.6% |
SENSEX | 1.9% |
0.1% |
10.9% |
You may also like the below Video Courses